Positive Rheumatoid Arthritis Data for UCB, Trubion, Others

Data presented this weekend at the American College of Rheumatology‘s annual meeting indicated that rheumatoid arthritis patients who adhered to a prescription drug regimen had better medical outcomes and lower medical costs, Reuters reports. The study looked at the medical  and pharmacy claims of RA...

BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle

By Mike Havrilla BioMedReports.com BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that develops new indications for approved drug compounds by applying its proprietary drug delivery technology platform, BEMA (BioErodible MucoAdhesive) Film Technology, while seeking FDA approval...

DATATRAK: Low Valuation, Improving Results

By Mike Havrilla on 10/12/09 www.MikeHavRx.com DATATRAK International Inc. (OTC: DATA.PK) is a clinical trials information technology (IT) and services company that is focused on increasing its share of an estimated $720 million (M) Electronic Data Capture (EDC) market opportunity (with about 50% or $360M of...

Onyx Pharmaceuticals to Acquire Proteolix

Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash, Bloomberg reports. The acquisition will provide Onyx with a late-stage, next-generation therapy to treat multiple myeloma, a form of blood cancer that affects over 180,000 people worldwide. Shares...

Positive Phase II Data for Peregrine’s Lung Cancer Treatment

Peregrine Pharmaceuticals reported positive Phase II data in a clinical trial of bavituximab in patients with a deadly form of lung cancer. Patients with non-small cell lung cancer (NSCLC) who took bavituximab in conjunction with the chemotherapy drugs carboplatin and paclitaxel had a progression-free...

Biotech News Out of Quebec

Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.  Medicago will work with the Army’s Edgewood Chemical Biological Center on the production of  industrial enzymes, which speed up chemical...

Two Pharma Companies to Offer Discounted Shares

Repros and Targacept have announced plans to offer shares in their respective companies at a reduced cost.  Both pharmaceutical companies are seeking additional capital to fund their drug development pipelines. Repros will sell 3.5 million common shares at $1.27 apiece to institutional investors for gross...

Inovio Biomedical (AMEX: INO): A DNA Vaccine Delivery Innovator

By Mike Havrilla, BioMedReports Inovio Biomedical (AMEX: INO) is developing a robust pre-clinical and early clinical stage pipeline of innovative DNA-based vaccines and therapeutics that target cancer, influenza, and other infectious diseases (e.g. HIV) based on its SynCon DNA vaccine construct and...